832 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104
United States of America
Dr. Bisson's career goal is to use clinical research to improve the health of adults with Human Immunodeficiency Virus (HIV) and/or tuberculosis (TB). As an Associate Professor of Medicine and Epidemiology at the University of Pennsylvania, he has focused on relating how immune function relates to clinical outcomes in HIV/TB in order to identify new treatments and treatment strategies. Working extensively in sub-Saharan Africa, his work has elucidated how cellular immune function specific to mycobacteria relates to patient outcomes including pulmonary inflammation, lung function , immune reconstitution inflammatory syndrome, and survival. Ongoing studies are evaluating immune mediators of lung damage in HIV/TB, the role of inflammasomes in TB-associated inflammation, and imatinib besylate as a host-directed therapy for TB.
University of Pennsylvania Perelman School of Medicine (Primary)
Ben Z. Stanger, MD, PhD is the representative at this institution.